Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517360 · ClinicalTrials.gov registry record · Phase 1
Pharmacological Approach to Improve the Outcome of Social Cognition Training
A Phase 1 study, sponsored by VA Greater Los Angeles Healthcare System.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT01517360 is a Phase 1 study that has completed, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 27 participants.
The verdict
NCT01517360, a Phase 1 study, has completed, sponsored by VA Greater Los Angeles Healthcare System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study will evaluate whether oxytocin will facilitate the learning of social cognitive skills in schizophrenia patients who receive 12 sessions of Social Cognitive Skills Training (SCST). The primary hypothesis is that schizophrenia subjects who are treated with oxytocin will demonstrate greater improvements in a summary measure of social cognition than subjects treated with placebo over the course of SCST.
Interventions
- OTHER Placebo
- DRUG Oxytocin
- BEHAVIORAL Social Cognitive Skills Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01517360
The ClinicalTrials.gov registry entry for NCT01517360 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01517360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01517360 about?
NCT01517360 is a clinical study titled "Pharmacological Approach to Improve the Outcome of Social Cognition Training". This study will evaluate whether oxytocin will facilitate the learning of social cognitive skills in schizophrenia patients who receive 12 sessions of Social Cognitive Skills Training (SCST). The primary hypothesis is that schizophrenia subjects who are treated with oxytocin will demonstrate greater...
What is the current status of trial NCT01517360?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2012-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01517360?
The interventions under investigation include: Placebo (OTHER), Oxytocin (DRUG), Social Cognitive Skills Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01517360?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.